Matisse Capital’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
SCM
RCM
RJA
AW
WP
Matisse Capital's BCAT Position: Q2 2023 in Review
Matisse Capital sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2023, closing a stake of 65,640 shares — an estimated $994K sold.
Matisse Capital first reported a position in BCAT in Q2 2022 and held it in 4 quarters. The position peaked at $994K in Q1 2023. 72 funds tracked by Wall St. Rank hold BCAT as of Q2 2023.
- Matisse Capital reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2023 after selling out during the quarter.
- Matisse Capital sold 65,640 BlackRock Capital Allocation Term Trust shares in Q2 2023, an estimated $994K.
- Matisse Capital first reported a position in BlackRock Capital Allocation Term Trust in Q2 2022 and held it in 4 quarters.
- Matisse Capital's BlackRock Capital Allocation Term Trust position peaked at $994K in Q1 2023.
- 72 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2023.
Based on Matisse Capital's 13F filing for Q2 2023, filed 2 Aug 2023.